VCU Health is one of a dozen hospitals nationwide at the forefront of a pivotal clinical trial that could revolutionize ...

Karter Nichols, a seven-year-old basketball player, has overcome numerous surgeries and illnesses to continue playing for his ...

At just two months old, Sainabou's head began to grow rapidly, and since then, her mother has been in a constant state of ...

CereVasc today announced the first patient randomized to and treated with the eShunt system in its STRIDE clinical trial.

CereVasc, Inc. announced the randomization of the first patient in the multicenter STRIDE clinical trial of the company’ ...

CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, announced ...

Kolkata: The life of a four-year-old boy suffering from ‘early-onset hydrocephalus' was saved at a city private hospital ...

WHEN a 44-year-old man began experiencing a common symptom experienced by millions, he decided to get checked out by medical ...

The 44-year-old started feeling a mild pain in his leg, which prompted him to visit his doctor two weeks later.

(B) Brain MRI demonstrating ventriculomegaly and evidence of subcortical ischemic changes. Both patients' idiopathic normal pressure hydrocephalus symptoms improved following shunt placement.

The global hydrocephalus shunt market is poised for steady expansion, with Future Market Insights (FMI) projecting a market value of USD 692.25 million by 2034, up from USD 546.09 million in 2024.

The researchers are developing the low-profile shunt to treat fetal hydrocephalus, a condition involving the buildup of cerebrospinal fluid in or around the brain. According to the University of ...